

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of clathrin-mediated endocytosis (GO:2000369) | 7.83197204 |
| 2 | positive regulation of antigen processing and presentation (GO:0002579) | 7.34743693 |
| 3 | urinary tract smooth muscle contraction (GO:0014848) | 6.60149721 |
| 4 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 6.38832457 |
| 5 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 6.34951994 |
| 6 | pharyngeal system development (GO:0060037) | 6.24275424 |
| 7 | regulation of acrosome reaction (GO:0060046) | 6.20942150 |
| 8 | reproduction (GO:0000003) | 6.05421302 |
| 9 | collecting duct development (GO:0072044) | 5.84248038 |
| 10 | regulation of antigen processing and presentation (GO:0002577) | 5.74722261 |
| 11 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.72267355 |
| 12 | cell proliferation in forebrain (GO:0021846) | 5.52427058 |
| 13 | prostanoid metabolic process (GO:0006692) | 5.49454024 |
| 14 | prostaglandin metabolic process (GO:0006693) | 5.49454024 |
| 15 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 5.43538195 |
| 16 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 5.21335050 |
| 17 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.17476616 |
| 18 | spinal cord association neuron differentiation (GO:0021527) | 5.09789779 |
| 19 | endocrine hormone secretion (GO:0060986) | 5.08816056 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.07578333 |
| 21 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 5.03071472 |
| 22 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 5.03071472 |
| 23 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.81195289 |
| 24 | response to lipoprotein particle (GO:0055094) | 4.79323033 |
| 25 | pattern specification involved in kidney development (GO:0061004) | 4.77470573 |
| 26 | urogenital system development (GO:0001655) | 4.75293368 |
| 27 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.65430668 |
| 28 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 4.60407805 |
| 29 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 4.60407805 |
| 30 | positive regulation of metanephros development (GO:0072216) | 4.48938275 |
| 31 | interkinetic nuclear migration (GO:0022027) | 4.38684711 |
| 32 | histone H4-K12 acetylation (GO:0043983) | 4.37423996 |
| 33 | multicellular organismal movement (GO:0050879) | 4.35174028 |
| 34 | musculoskeletal movement (GO:0050881) | 4.35174028 |
| 35 | peristalsis (GO:0030432) | 4.34379880 |
| 36 | serotonin metabolic process (GO:0042428) | 4.33231674 |
| 37 | plasma membrane fusion (GO:0045026) | 4.32072686 |
| 38 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.28635737 |
| 39 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.18343056 |
| 40 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.18343056 |
| 41 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.18343056 |
| 42 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.17075165 |
| 43 | metanephric nephron epithelium development (GO:0072243) | 4.13348796 |
| 44 | regulation of Cdc42 GTPase activity (GO:0043088) | 4.08447260 |
| 45 | regulation of bile acid biosynthetic process (GO:0070857) | 4.02377110 |
| 46 | regulation of activation of Janus kinase activity (GO:0010533) | 3.96471095 |
| 47 | macroautophagy (GO:0016236) | 3.90580877 |
| 48 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.85708549 |
| 49 | negative regulation of sodium ion transport (GO:0010766) | 3.83939625 |
| 50 | positive regulation of mRNA catabolic process (GO:0061014) | 3.78367528 |
| 51 | metanephric epithelium development (GO:0072207) | 3.78082501 |
| 52 | respiratory burst (GO:0045730) | 3.72060140 |
| 53 | negative regulation of protein localization to cell surface (GO:2000009) | 3.69043199 |
| 54 | sulfur amino acid catabolic process (GO:0000098) | 3.63438871 |
| 55 | locomotory exploration behavior (GO:0035641) | 3.63196537 |
| 56 | epithelial structure maintenance (GO:0010669) | 3.55043073 |
| 57 | GPI anchor biosynthetic process (GO:0006506) | 3.50755365 |
| 58 | regulation of hippo signaling (GO:0035330) | 3.50065677 |
| 59 | primary amino compound metabolic process (GO:1901160) | 3.49939639 |
| 60 | opioid receptor signaling pathway (GO:0038003) | 3.48635454 |
| 61 | regulation of respiratory burst (GO:0060263) | 3.47392848 |
| 62 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.46707803 |
| 63 | GPI anchor metabolic process (GO:0006505) | 3.44940226 |
| 64 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.40044890 |
| 65 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.39123870 |
| 66 | brown fat cell differentiation (GO:0050873) | 3.35071824 |
| 67 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.32472146 |
| 68 | cardiovascular system development (GO:0072358) | 3.30451784 |
| 69 | negative regulation of endopeptidase activity (GO:0010951) | 3.29924515 |
| 70 | response to misfolded protein (GO:0051788) | 3.29276540 |
| 71 | positive regulation of mRNA 3-end processing (GO:0031442) | 3.28596075 |
| 72 | mesenchymal to epithelial transition (GO:0060231) | 3.24550865 |
| 73 | negative regulation of peptidase activity (GO:0010466) | 3.20145615 |
| 74 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.20015892 |
| 75 | cranial nerve structural organization (GO:0021604) | 3.19788977 |
| 76 | white fat cell differentiation (GO:0050872) | 3.15623846 |
| 77 | cell differentiation in spinal cord (GO:0021515) | 3.15150820 |
| 78 | sodium-independent organic anion transport (GO:0043252) | 3.14945514 |
| 79 | low-density lipoprotein particle clearance (GO:0034383) | 3.14849086 |
| 80 | metanephric mesenchyme development (GO:0072075) | 3.13199423 |
| 81 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.12112112 |
| 82 | fibroblast migration (GO:0010761) | 3.10935894 |
| 83 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.10281616 |
| 84 | regulation of mRNA catabolic process (GO:0061013) | 3.09747128 |
| 85 | cell differentiation in hindbrain (GO:0021533) | 3.08952611 |
| 86 | forebrain neuron differentiation (GO:0021879) | 3.06291571 |
| 87 | platelet dense granule organization (GO:0060155) | 3.04405898 |
| 88 | intra-S DNA damage checkpoint (GO:0031573) | 3.03051082 |
| 89 | regulation of metanephros development (GO:0072215) | 2.99248441 |
| 90 | regulation of mRNA 3-end processing (GO:0031440) | 2.98390458 |
| 91 | nephron tubule development (GO:0072080) | 2.97779116 |
| 92 | smooth muscle contraction (GO:0006939) | 2.97360046 |
| 93 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.93956401 |
| 94 | positive regulation of response to oxidative stress (GO:1902884) | 2.93956401 |
| 95 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.90657677 |
| 96 | indole-containing compound metabolic process (GO:0042430) | 2.89735307 |
| 97 | exploration behavior (GO:0035640) | 2.88488222 |
| 98 | regulation of coenzyme metabolic process (GO:0051196) | 2.86670601 |
| 99 | regulation of cofactor metabolic process (GO:0051193) | 2.86670601 |
| 100 | embryonic epithelial tube formation (GO:0001838) | 2.86618062 |
| 101 | valine metabolic process (GO:0006573) | 2.86151105 |
| 102 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.84315841 |
| 103 | regulation of fatty acid oxidation (GO:0046320) | 2.82975223 |
| 104 | negative regulation of metanephros development (GO:0072217) | 2.82093780 |
| 105 | positive regulation of action potential (GO:0045760) | 2.81753794 |
| 106 | regulation of stem cell maintenance (GO:2000036) | 2.79293122 |
| 107 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.78197093 |
| 108 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.77962324 |
| 109 | specification of organ identity (GO:0010092) | 2.76239521 |
| 110 | positive regulation of natural killer cell activation (GO:0032816) | 2.75873693 |
| 111 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.75399202 |
| 112 | regulation of glomerulus development (GO:0090192) | 2.75295646 |
| 113 | regulation of sulfur metabolic process (GO:0042762) | 2.74867400 |
| 114 | negative regulation of protein autophosphorylation (GO:0031953) | 2.74362075 |
| 115 | positive regulation of mesonephros development (GO:0061213) | 2.74330883 |
| 116 | epithelial tube formation (GO:0072175) | 2.72766398 |
| 117 | regulation of gene silencing by RNA (GO:0060966) | 2.72686658 |
| 118 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.72686658 |
| 119 | regulation of gene silencing by miRNA (GO:0060964) | 2.72686658 |
| 120 | indole-containing compound catabolic process (GO:0042436) | 2.71784834 |
| 121 | indolalkylamine catabolic process (GO:0046218) | 2.71784834 |
| 122 | tryptophan catabolic process (GO:0006569) | 2.71784834 |
| 123 | phospholipid catabolic process (GO:0009395) | 2.71291455 |
| 124 | cellular anion homeostasis (GO:0030002) | 2.67204563 |
| 125 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.67083318 |
| 126 | positive regulation of respiratory burst (GO:0060267) | 2.63498469 |
| 127 | triglyceride catabolic process (GO:0019433) | 2.58911525 |
| 128 | nephron tubule formation (GO:0072079) | 2.58222217 |
| 129 | trivalent inorganic anion homeostasis (GO:0072506) | 2.56108723 |
| 130 | phosphate ion homeostasis (GO:0055062) | 2.56108723 |
| 131 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.55373330 |
| 132 | polyol transport (GO:0015791) | 2.53593451 |
| 133 | negative regulation of endocytosis (GO:0045806) | 2.52818095 |
| 134 | negative regulation of lipase activity (GO:0060192) | 2.49361152 |
| 135 | positive regulation of cholesterol transport (GO:0032376) | 2.46939451 |
| 136 | positive regulation of sterol transport (GO:0032373) | 2.46939451 |
| 137 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.46581333 |
| 138 | cytolysis (GO:0019835) | 2.44663068 |
| 139 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.43380371 |
| 140 | embryonic digestive tract morphogenesis (GO:0048557) | 2.43373854 |
| 141 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.43329619 |
| 142 | xenobiotic catabolic process (GO:0042178) | 2.41316543 |
| 143 | regulation of complement activation (GO:0030449) | 2.40692444 |
| 144 | positive regulation of glomerulus development (GO:0090193) | 2.37354472 |
| 145 | cellular response to heat (GO:0034605) | 2.37316713 |
| 146 | limb bud formation (GO:0060174) | 2.36977996 |
| 147 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.35936590 |
| 148 | acylglycerol catabolic process (GO:0046464) | 2.35195575 |
| 149 | neutral lipid catabolic process (GO:0046461) | 2.35195575 |
| 150 | negative regulation of viral transcription (GO:0032897) | 2.35019046 |
| 151 | endosome to pigment granule transport (GO:0043485) | 2.29808630 |
| 152 | endosome to melanosome transport (GO:0035646) | 2.29808630 |
| 153 | negative regulation of epidermis development (GO:0045683) | 2.27446512 |
| 154 | regulation of protein activation cascade (GO:2000257) | 2.23594297 |
| 155 | cellular sodium ion homeostasis (GO:0006883) | 2.23232871 |
| 156 | cellular component maintenance (GO:0043954) | 2.21920994 |
| 157 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.20965088 |
| 158 | regulation of response to reactive oxygen species (GO:1901031) | 2.16947988 |
| 159 | nucleobase catabolic process (GO:0046113) | 2.16920052 |
| 160 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.16742109 |
| 161 | negative regulation of proteolysis (GO:0045861) | 2.15678710 |
| 162 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.15619156 |
| 163 | mannose metabolic process (GO:0006013) | 2.12236058 |
| 164 | cranial nerve morphogenesis (GO:0021602) | 2.11980963 |
| 165 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.11420261 |
| 166 | positive regulation of filopodium assembly (GO:0051491) | 2.11334196 |
| 167 | mesonephros development (GO:0001823) | 2.09927529 |
| 168 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.09165729 |
| 169 | regulation of natural killer cell activation (GO:0032814) | 2.09047579 |
| 170 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.08396436 |
| 171 | anterograde synaptic vesicle transport (GO:0048490) | 2.08223374 |
| 172 | response to nitrosative stress (GO:0051409) | 2.08212974 |
| 173 | metanephric nephron tubule development (GO:0072234) | 2.07333389 |
| 174 | metanephric tubule development (GO:0072170) | 2.07333389 |
| 175 | cellular response to epinephrine stimulus (GO:0071872) | 2.07172372 |
| 176 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.07019729 |
| 177 | glomerular filtration (GO:0003094) | 2.06696988 |
| 178 | developmental pigmentation (GO:0048066) | 2.06523909 |
| 179 | negative regulation of oxidoreductase activity (GO:0051354) | 2.06162301 |
| 180 | photoreceptor cell differentiation (GO:0046530) | 2.04083838 |
| 181 | eye photoreceptor cell differentiation (GO:0001754) | 2.04083838 |
| 182 | positive regulation of digestive system process (GO:0060456) | 2.03962478 |
| 183 | sexual reproduction (GO:0019953) | 15.9902990 |
| 184 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 15.4449624 |
| 185 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 15.4449624 |
| 186 | antigen processing and presentation via MHC class Ib (GO:0002475) | 14.9445710 |
| 187 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 14.4281985 |
| 188 | antigen processing and presentation of endogenous antigen (GO:0019883) | 12.9153810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 8.07524443 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 4.29136203 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.40820098 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.84575352 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.58406204 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.55532088 |
| 7 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.40405017 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.28084032 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.21520942 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17307080 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.06393247 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.04931557 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.04274968 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.02121372 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93789080 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.90031307 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.88521067 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.84198846 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.84198846 |
| 20 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83819248 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.83657518 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80853483 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.79860206 |
| 24 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74342293 |
| 25 | STAT3_23295773_ChIP-Seq_U87_Human | 1.73607091 |
| 26 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.72783215 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.71771195 |
| 28 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.68452043 |
| 29 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68452043 |
| 30 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68424488 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.67222563 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.65362598 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64779653 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.60212021 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59272407 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59261036 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58086682 |
| 38 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.55928589 |
| 39 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.55302144 |
| 40 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.53617975 |
| 41 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.51690893 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.49331932 |
| 43 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.44801901 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.43590178 |
| 45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.42444992 |
| 46 | TP53_16413492_ChIP-PET_HCT116_Human | 1.42185585 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41900383 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40825697 |
| 49 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.39805734 |
| 50 | TCF4_23295773_ChIP-Seq_U87_Human | 1.37177191 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36350613 |
| 52 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.35806184 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35062270 |
| 54 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.33842222 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31849941 |
| 56 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.31045796 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24812599 |
| 58 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24360962 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.24173011 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23658916 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21108625 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.20641347 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.20379609 |
| 64 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.19739787 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19659256 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18249864 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.17968460 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17562170 |
| 69 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.17504165 |
| 70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16429204 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16187106 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16120839 |
| 73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15802786 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.15733628 |
| 75 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.15688682 |
| 76 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15217376 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14661056 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14300263 |
| 79 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13768673 |
| 80 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.13021069 |
| 81 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12947360 |
| 82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11876724 |
| 83 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11100990 |
| 84 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.10670741 |
| 85 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.09098862 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08737675 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08599410 |
| 88 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.08216515 |
| 89 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.07077425 |
| 90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.07077425 |
| 91 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06871350 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06458846 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06359847 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04546394 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04546394 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04539947 |
| 97 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04532268 |
| 98 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.04444281 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03684473 |
| 100 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02357796 |
| 101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01558606 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00665298 |
| 103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00169062 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00091800 |
| 105 | P300_19829295_ChIP-Seq_ESCs_Human | 0.98437754 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97873019 |
| 107 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.97262172 |
| 108 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.97212310 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97170864 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96640858 |
| 111 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.95691745 |
| 112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95443898 |
| 113 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95217302 |
| 114 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94624426 |
| 115 | AR_19668381_ChIP-Seq_PC3_Human | 0.94605864 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94497116 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94473957 |
| 118 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94340346 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92923624 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92717479 |
| 121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91626714 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91054123 |
| 123 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.90533961 |
| 124 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90454346 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89691675 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89105802 |
| 127 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.88762842 |
| 128 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87569754 |
| 129 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87120081 |
| 130 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87068793 |
| 131 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86071543 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85653598 |
| 133 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.84760995 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84740595 |
| 135 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84106859 |
| 136 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83561141 |
| 137 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82354852 |
| 138 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.82056124 |
| 139 | VDR_22108803_ChIP-Seq_LS180_Human | 0.81727872 |
| 140 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81528708 |
| 141 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80508415 |
| 142 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.80042317 |
| 143 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.79578170 |
| 144 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.78911035 |
| 145 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78765777 |
| 146 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.78752719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002102_abnormal_ear_morphology | 8.17142063 |
| 2 | MP0009840_abnormal_foam_cell | 4.96052490 |
| 3 | MP0005058_abnormal_lysosome_morphology | 4.02088008 |
| 4 | MP0005174_abnormal_tail_pigmentation | 3.30937446 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.23022099 |
| 6 | MP0002653_abnormal_ependyma_morphology | 3.06545345 |
| 7 | MP0000534_abnormal_ureter_morphology | 3.01666029 |
| 8 | MP0001485_abnormal_pinna_reflex | 2.60725739 |
| 9 | MP0000372_irregular_coat_pigmentation | 2.59316908 |
| 10 | MP0003136_yellow_coat_color | 2.52354491 |
| 11 | MP0005670_abnormal_white_adipose | 2.50658192 |
| 12 | MP0003646_muscle_fatigue | 2.46551553 |
| 13 | MP0004145_abnormal_muscle_electrophysio | 2.29881435 |
| 14 | MP0001756_abnormal_urination | 2.17312623 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.14284600 |
| 16 | MP0000462_abnormal_digestive_system | 2.11612464 |
| 17 | MP0008995_early_reproductive_senescence | 2.08866379 |
| 18 | MP0000538_abnormal_urinary_bladder | 2.08283243 |
| 19 | MP0000767_abnormal_smooth_muscle | 2.01356328 |
| 20 | MP0000778_abnormal_nervous_system | 1.98345013 |
| 21 | MP0003938_abnormal_ear_development | 1.94733598 |
| 22 | MP0000230_abnormal_systemic_arterial | 1.93254228 |
| 23 | MP0005171_absent_coat_pigmentation | 1.88737722 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.87815432 |
| 25 | MP0000015_abnormal_ear_pigmentation | 1.87061922 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 1.85669482 |
| 27 | MP0004381_abnormal_hair_follicle | 1.84152175 |
| 28 | MP0003690_abnormal_glial_cell | 1.83788969 |
| 29 | MP0001853_heart_inflammation | 1.83218297 |
| 30 | MP0001664_abnormal_digestion | 1.81600915 |
| 31 | MP0005360_urolithiasis | 1.76734839 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.75853219 |
| 33 | MP0002282_abnormal_trachea_morphology | 1.71515142 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.70317564 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.66251403 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.62059989 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.60295351 |
| 38 | MP0004858_abnormal_nervous_system | 1.59883890 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59577395 |
| 40 | MP0003942_abnormal_urinary_system | 1.56171981 |
| 41 | MP0002735_abnormal_chemical_nociception | 1.54664587 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.50205298 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.49269910 |
| 44 | MP0010386_abnormal_urinary_bladder | 1.45955962 |
| 45 | MP0005595_abnormal_vascular_smooth | 1.44159977 |
| 46 | MP0003045_fibrosis | 1.44088584 |
| 47 | MP0005620_abnormal_muscle_contractility | 1.44043327 |
| 48 | MP0001324_abnormal_eye_pigmentation | 1.43684219 |
| 49 | MP0004036_abnormal_muscle_relaxation | 1.43519964 |
| 50 | MP0009764_decreased_sensitivity_to | 1.41585050 |
| 51 | MP0003195_calcinosis | 1.40580145 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.39312605 |
| 53 | MP0000427_abnormal_hair_cycle | 1.37622541 |
| 54 | MP0009785_altered_susceptibility_to | 1.37425135 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.37214868 |
| 56 | MP0002272_abnormal_nervous_system | 1.35485997 |
| 57 | MP0005248_abnormal_Harderian_gland | 1.33874477 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.32141990 |
| 59 | MP0004130_abnormal_muscle_cell | 1.31042363 |
| 60 | MP0006082_CNS_inflammation | 1.29002452 |
| 61 | MP0009763_increased_sensitivity_to | 1.25759670 |
| 62 | MP0003724_increased_susceptibility_to | 1.25612194 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.24808338 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.23510046 |
| 65 | MP0002734_abnormal_mechanical_nocicepti | 1.22385944 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.18930692 |
| 67 | MP0002060_abnormal_skin_morphology | 1.18572000 |
| 68 | MP0003075_altered_response_to | 1.18426876 |
| 69 | MP0000647_abnormal_sebaceous_gland | 1.17962830 |
| 70 | MP0001440_abnormal_grooming_behavior | 1.15490649 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.14477749 |
| 72 | MP0003186_abnormal_redox_activity | 1.13350356 |
| 73 | MP0000371_diluted_coat_color | 1.13156516 |
| 74 | MP0003936_abnormal_reproductive_system | 1.13106559 |
| 75 | MP0000631_abnormal_neuroendocrine_gland | 1.13071401 |
| 76 | MP0008569_lethality_at_weaning | 1.11331570 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.08452860 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 1.08310365 |
| 79 | MP0002234_abnormal_pharynx_morphology | 1.07676617 |
| 80 | MP0001963_abnormal_hearing_physiology | 1.06844349 |
| 81 | MP0004272_abnormal_basement_membrane | 1.02747738 |
| 82 | MP0003953_abnormal_hormone_level | 1.01931790 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.01538881 |
| 84 | MP0001486_abnormal_startle_reflex | 0.97750714 |
| 85 | MP0001270_distended_abdomen | 0.97402335 |
| 86 | MP0003890_abnormal_embryonic-extraembry | 0.96038029 |
| 87 | MP0004885_abnormal_endolymph | 0.95573754 |
| 88 | MP0009745_abnormal_behavioral_response | 0.95525332 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.94853625 |
| 90 | MP0005275_abnormal_skin_tensile | 0.94211294 |
| 91 | MP0000343_altered_response_to | 0.91742631 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.91674137 |
| 93 | MP0004924_abnormal_behavior | 0.91510589 |
| 94 | MP0005386_behavior/neurological_phenoty | 0.91510589 |
| 95 | MP0002067_abnormal_sensory_capabilities | 0.91158227 |
| 96 | MP0002736_abnormal_nociception_after | 0.90391367 |
| 97 | MP0000685_abnormal_immune_system | 0.90149216 |
| 98 | MP0000681_abnormal_thyroid_gland | 0.90082349 |
| 99 | MP0000026_abnormal_inner_ear | 0.89999049 |
| 100 | MP0002168_other_aberrant_phenotype | 0.89415098 |
| 101 | MP0001727_abnormal_embryo_implantation | 0.89132157 |
| 102 | MP0005310_abnormal_salivary_gland | 0.88425828 |
| 103 | MP0003436_decreased_susceptibility_to | 0.87779013 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.86144537 |
| 105 | MP0004085_abnormal_heartbeat | 0.85233384 |
| 106 | MP0002069_abnormal_eating/drinking_beha | 0.84823231 |
| 107 | MP0003879_abnormal_hair_cell | 0.84082899 |
| 108 | MP0003632_abnormal_nervous_system | 0.83358712 |
| 109 | MP0003937_abnormal_limbs/digits/tail_de | 0.82711021 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.82402062 |
| 111 | MP0002557_abnormal_social/conspecific_i | 0.82349283 |
| 112 | MP0000579_abnormal_nail_morphology | 0.82039235 |
| 113 | MP0006292_abnormal_olfactory_placode | 0.81767253 |
| 114 | MP0005330_cardiomyopathy | 0.81661144 |
| 115 | MP0009780_abnormal_chondrocyte_physiolo | 0.81391586 |
| 116 | MP0002064_seizures | 0.81137416 |
| 117 | MP0001968_abnormal_touch/_nociception | 0.80984026 |
| 118 | MP0000377_abnormal_hair_follicle | 0.80886322 |
| 119 | MP0005187_abnormal_penis_morphology | 0.80576310 |
| 120 | MP0001879_abnormal_lymphatic_vessel | 0.80531184 |
| 121 | MP0004134_abnormal_chest_morphology | 0.80406043 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.80316785 |
| 123 | MP0004859_abnormal_synaptic_plasticity | 0.79658822 |
| 124 | MP0009046_muscle_twitch | 0.79216367 |
| 125 | MP0005025_abnormal_response_to | 0.79115831 |
| 126 | MP0008872_abnormal_physiological_respon | 0.78848453 |
| 127 | MP0008004_abnormal_stomach_pH | 0.78629075 |
| 128 | MP0002063_abnormal_learning/memory/cond | 0.77563626 |
| 129 | MP0004142_abnormal_muscle_tone | 0.76849917 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76786601 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.76710916 |
| 132 | MP0000566_synostosis | 0.76093542 |
| 133 | MP0002006_tumorigenesis | 0.74941415 |
| 134 | MP0002837_dystrophic_cardiac_calcinosis | 0.74888059 |
| 135 | MP0001188_hyperpigmentation | 0.74407699 |
| 136 | MP0000569_abnormal_digit_pigmentation | 0.73871365 |
| 137 | MP0003635_abnormal_synaptic_transmissio | 0.73810602 |
| 138 | MP0005334_abnormal_fat_pad | 0.73803345 |
| 139 | MP0005000_abnormal_immune_tolerance | 0.73306223 |
| 140 | MP0003943_abnormal_hepatobiliary_system | 0.72938147 |
| 141 | MP0005408_hypopigmentation | 0.72917913 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.72511885 |
| 143 | MP0005220_abnormal_exocrine_pancreas | 0.72264469 |
| 144 | MP0005365_abnormal_bile_salt | 0.72126008 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.71278725 |
| 146 | MP0004947_skin_inflammation | 0.71193273 |
| 147 | MP0002419_abnormal_innate_immunity | 0.71177637 |
| 148 | MP0009643_abnormal_urine_homeostasis | 0.70112597 |
| 149 | MP0002572_abnormal_emotion/affect_behav | 0.69621459 |
| 150 | MP0002882_abnormal_neuron_morphology | 0.69507941 |
| 151 | MP0001970_abnormal_pain_threshold | 0.69342624 |
| 152 | MP0002136_abnormal_kidney_physiology | 0.69031177 |
| 153 | MP0003183_abnormal_peptide_metabolism | 0.68787088 |
| 154 | MP0004270_analgesia | 0.68464779 |
| 155 | MP0003806_abnormal_nucleotide_metabolis | 0.68016525 |
| 156 | MP0009115_abnormal_fat_cell | 0.67874307 |
| 157 | MP0001765_abnormal_ion_homeostasis | 0.66907277 |
| 158 | MP0002152_abnormal_brain_morphology | 0.66092205 |
| 159 | MP0005387_immune_system_phenotype | 0.65944343 |
| 160 | MP0001790_abnormal_immune_system | 0.65944343 |
| 161 | MP0005195_abnormal_posterior_eye | 0.65566660 |
| 162 | MP0003698_abnormal_male_reproductive | 0.65547092 |
| 163 | MP0002177_abnormal_outer_ear | 0.65217413 |
| 164 | MP0001835_abnormal_antigen_presentation | 0.65188471 |
| 165 | MP0005448_abnormal_energy_balance | 0.64999927 |
| 166 | MP0000920_abnormal_myelination | 0.64850123 |
| 167 | MP0002229_neurodegeneration | 0.64637693 |
| 168 | MP0001533_abnormal_skeleton_physiology | 0.64317417 |
| 169 | MP0003638_abnormal_response/metabolism_ | 0.64301375 |
| 170 | MP0004185_abnormal_adipocyte_glucose | 0.63799510 |
| 171 | MP0000163_abnormal_cartilage_morphology | 0.63516174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Progressive cerebellar ataxia (HP:0002073) | 7.61458016 |
| 2 | Choroideremia (HP:0001139) | 7.58958715 |
| 3 | Abnormality of the fovea (HP:0000493) | 7.34437540 |
| 4 | Abnormality of secondary sexual hair (HP:0009888) | 6.79490401 |
| 5 | Abnormality of the axillary hair (HP:0100134) | 6.79490401 |
| 6 | Abnormal rod and cone electroretinograms (HP:0008323) | 6.43555384 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 6.23915402 |
| 8 | Genetic anticipation (HP:0003743) | 6.02010812 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.61083352 |
| 10 | Bony spicule pigmentary retinopathy (HP:0007737) | 5.34221588 |
| 11 | Complement deficiency (HP:0004431) | 5.20484403 |
| 12 | 11 pairs of ribs (HP:0000878) | 4.79232193 |
| 13 | Aortic aneurysm (HP:0004942) | 4.43622663 |
| 14 | Acute lymphatic leukemia (HP:0006721) | 4.27680826 |
| 15 | Hyperventilation (HP:0002883) | 4.25255910 |
| 16 | Hypopigmentation of the fundus (HP:0007894) | 4.06808548 |
| 17 | Shawl scrotum (HP:0000049) | 4.01379809 |
| 18 | Abnormality of complement system (HP:0005339) | 3.95403939 |
| 19 | Chorioretinal atrophy (HP:0000533) | 3.88004102 |
| 20 | Stridor (HP:0010307) | 3.86558874 |
| 21 | Hypothermia (HP:0002045) | 3.86257816 |
| 22 | Action tremor (HP:0002345) | 3.85515302 |
| 23 | Breast hypoplasia (HP:0003187) | 3.52076510 |
| 24 | Clumsiness (HP:0002312) | 3.49935140 |
| 25 | Nonprogressive disorder (HP:0003680) | 3.49225418 |
| 26 | Vascular calcification (HP:0004934) | 3.45070466 |
| 27 | Neurofibrillary tangles (HP:0002185) | 3.39338160 |
| 28 | Congenital sensorineural hearing impairment (HP:0008527) | 3.37713906 |
| 29 | Reticulocytopenia (HP:0001896) | 3.25856865 |
| 30 | Protruding tongue (HP:0010808) | 3.25667658 |
| 31 | Hand muscle atrophy (HP:0009130) | 3.22896233 |
| 32 | Broad-based gait (HP:0002136) | 3.20684035 |
| 33 | Hip contracture (HP:0003273) | 3.15655990 |
| 34 | Diaphragmatic weakness (HP:0009113) | 3.12106791 |
| 35 | Cardiovascular calcification (HP:0011915) | 3.11355857 |
| 36 | Tongue fasciculations (HP:0001308) | 3.08373750 |
| 37 | Hyperphosphatemia (HP:0002905) | 3.05558175 |
| 38 | Blue irides (HP:0000635) | 3.02567611 |
| 39 | Aplasia of the musculature (HP:0100854) | 3.01625491 |
| 40 | Dysmetric saccades (HP:0000641) | 2.99927476 |
| 41 | Missing ribs (HP:0000921) | 2.93297373 |
| 42 | Visual hallucinations (HP:0002367) | 2.90589250 |
| 43 | Cerebral inclusion bodies (HP:0100314) | 2.88188106 |
| 44 | Bronchomalacia (HP:0002780) | 2.84606101 |
| 45 | Gaze-evoked nystagmus (HP:0000640) | 2.83008854 |
| 46 | Muscle fibrillation (HP:0010546) | 2.77944923 |
| 47 | Hyperglycinuria (HP:0003108) | 2.77912607 |
| 48 | Limited hip movement (HP:0008800) | 2.75869476 |
| 49 | Clubbing of toes (HP:0100760) | 2.75587344 |
| 50 | Wide cranial sutures (HP:0010537) | 2.72110859 |
| 51 | Abnormal drinking behavior (HP:0030082) | 2.70504075 |
| 52 | Polydipsia (HP:0001959) | 2.70504075 |
| 53 | Widely patent fontanelles and sutures (HP:0004492) | 2.68848147 |
| 54 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.67201384 |
| 55 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.63893944 |
| 56 | Aplasia of the phalanges of the hand (HP:0009802) | 2.63893944 |
| 57 | Aplasia involving bones of the extremities (HP:0009825) | 2.63893944 |
| 58 | Congenital stationary night blindness (HP:0007642) | 2.62355523 |
| 59 | Limb ataxia (HP:0002070) | 2.61927417 |
| 60 | Duplicated collecting system (HP:0000081) | 2.59525121 |
| 61 | Hypoplastic nipples (HP:0002557) | 2.58781129 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.57225625 |
| 63 | Aortic dissection (HP:0002647) | 2.55005641 |
| 64 | Abnormality of macular pigmentation (HP:0008002) | 2.54838376 |
| 65 | Distal upper limb amyotrophy (HP:0007149) | 2.54769218 |
| 66 | Upper limb amyotrophy (HP:0009129) | 2.54769218 |
| 67 | Tubulointerstitial fibrosis (HP:0005576) | 2.54122743 |
| 68 | Macroglossia (HP:0000158) | 2.54068390 |
| 69 | Confusion (HP:0001289) | 2.53967503 |
| 70 | Metaphyseal cupping (HP:0003021) | 2.53854528 |
| 71 | Partial duplication of thumb phalanx (HP:0009944) | 2.50269241 |
| 72 | Ventricular fibrillation (HP:0001663) | 2.45041908 |
| 73 | Decreased circulating renin level (HP:0003351) | 2.42220218 |
| 74 | Sparse lateral eyebrow (HP:0005338) | 2.41963058 |
| 75 | Facial shape deformation (HP:0011334) | 2.40776622 |
| 76 | Potter facies (HP:0002009) | 2.40776622 |
| 77 | Thyroid-stimulating hormone excess (HP:0002925) | 2.38253803 |
| 78 | Patellar aplasia (HP:0006443) | 2.36779713 |
| 79 | Abnormality of cochlea (HP:0000375) | 2.34952505 |
| 80 | Fair hair (HP:0002286) | 2.33493109 |
| 81 | Goiter (HP:0000853) | 2.33325575 |
| 82 | Hypophosphatemic rickets (HP:0004912) | 2.31989583 |
| 83 | Intention tremor (HP:0002080) | 2.28545746 |
| 84 | Cerebral palsy (HP:0100021) | 2.27546267 |
| 85 | Pili torti (HP:0003777) | 2.24740104 |
| 86 | Neoplasm of the heart (HP:0100544) | 2.24547112 |
| 87 | Abnormality of the parietal bone (HP:0002696) | 2.23631819 |
| 88 | Prolonged QT interval (HP:0001657) | 2.21993455 |
| 89 | Facial diplegia (HP:0001349) | 2.19576803 |
| 90 | Nasolacrimal duct obstruction (HP:0000579) | 2.16975993 |
| 91 | Abnormality of the nasal septum (HP:0000419) | 2.16649015 |
| 92 | Albinism (HP:0001022) | 2.15103494 |
| 93 | Seborrheic dermatitis (HP:0001051) | 2.14939914 |
| 94 | Irregular vertebral endplates (HP:0003301) | 2.14922707 |
| 95 | Biconcave vertebral bodies (HP:0004586) | 2.14782390 |
| 96 | Aortic regurgitation (HP:0001659) | 2.13748577 |
| 97 | Osteomalacia (HP:0002749) | 2.13180359 |
| 98 | Bone cyst (HP:0012062) | 2.12852176 |
| 99 | Partial duplication of the phalanx of hand (HP:0009999) | 2.12265701 |
| 100 | Hypertriglyceridemia (HP:0002155) | 2.12010744 |
| 101 | Generalized hypopigmentation of hair (HP:0011358) | 2.11057840 |
| 102 | Absent radius (HP:0003974) | 2.10950165 |
| 103 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.10934745 |
| 104 | Premature loss of primary teeth (HP:0006323) | 2.09944449 |
| 105 | Short humerus (HP:0005792) | 2.06507529 |
| 106 | Loss of speech (HP:0002371) | 2.06292829 |
| 107 | Myocardial infarction (HP:0001658) | 2.05706972 |
| 108 | Oligomenorrhea (HP:0000876) | 2.05657965 |
| 109 | Dysostosis multiplex (HP:0000943) | 2.05304116 |
| 110 | Duplication of thumb phalanx (HP:0009942) | 2.05266112 |
| 111 | Agitation (HP:0000713) | 2.05197427 |
| 112 | Absent hair (HP:0002298) | 2.04440210 |
| 113 | Inability to walk (HP:0002540) | 2.03764734 |
| 114 | Morphological abnormality of the inner ear (HP:0011390) | 2.03639430 |
| 115 | Aplasia involving forearm bones (HP:0009822) | 2.03127669 |
| 116 | Absent forearm bone (HP:0003953) | 2.03127669 |
| 117 | Absent speech (HP:0001344) | 2.02224526 |
| 118 | Abnormality of glycine metabolism (HP:0010895) | 2.01277902 |
| 119 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.01277902 |
| 120 | Eczematoid dermatitis (HP:0000976) | 2.01239891 |
| 121 | Ankle clonus (HP:0011448) | 2.00476889 |
| 122 | Abnormality of the renal collecting system (HP:0004742) | 1.98569966 |
| 123 | Abnormality of the musculature of the hand (HP:0001421) | 1.98059817 |
| 124 | Hypoplastic labia majora (HP:0000059) | 1.96721385 |
| 125 | Bicornuate uterus (HP:0000813) | 1.95172611 |
| 126 | Hypoplasia of the maxilla (HP:0000327) | 1.94049219 |
| 127 | Down-sloping shoulders (HP:0200021) | 1.94043712 |
| 128 | Flat cornea (HP:0007720) | 1.93902704 |
| 129 | Progressive inability to walk (HP:0002505) | 1.93428908 |
| 130 | Supranuclear gaze palsy (HP:0000605) | 1.92799541 |
| 131 | Systemic lupus erythematosus (HP:0002725) | 1.92468020 |
| 132 | Infantile muscular hypotonia (HP:0008947) | 1.88524347 |
| 133 | Vaginal atresia (HP:0000148) | 1.87440330 |
| 134 | Xerostomia (HP:0000217) | 1.87177981 |
| 135 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85917690 |
| 136 | Abnormality of alanine metabolism (HP:0010916) | 1.85917690 |
| 137 | Hyperalaninemia (HP:0003348) | 1.85917690 |
| 138 | Abnormality of the calcaneus (HP:0008364) | 1.85469259 |
| 139 | Polyuria (HP:0000103) | 1.84982170 |
| 140 | Tracheomalacia (HP:0002779) | 1.84803462 |
| 141 | Hemiplegia (HP:0002301) | 1.82965342 |
| 142 | Polar cataract (HP:0010696) | 1.79965943 |
| 143 | Fibular hypoplasia (HP:0003038) | 1.78289572 |
| 144 | Genital tract atresia (HP:0001827) | 1.78043504 |
| 145 | Birth length less than 3rd percentile (HP:0003561) | 1.78042198 |
| 146 | Abnormality of the labia majora (HP:0012881) | 1.77921055 |
| 147 | Hyperglycinemia (HP:0002154) | 1.77740722 |
| 148 | Abnormality of the vocal cords (HP:0008777) | 1.77431930 |
| 149 | Hypoventilation (HP:0002791) | 1.76105218 |
| 150 | Midline defect of the nose (HP:0004122) | 1.75467535 |
| 151 | Chromsome breakage (HP:0040012) | 1.75274645 |
| 152 | Focal segmental glomerulosclerosis (HP:0000097) | 1.74666715 |
| 153 | Periodontitis (HP:0000704) | 1.74504383 |
| 154 | Hypoplasia of the ulna (HP:0003022) | 1.73868861 |
| 155 | Chin dimple (HP:0010751) | 1.73112515 |
| 156 | Short tibia (HP:0005736) | 1.72701321 |
| 157 | Acanthosis nigricans (HP:0000956) | 1.71948896 |
| 158 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.71939337 |
| 159 | White forelock (HP:0002211) | 1.71231672 |
| 160 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.71025711 |
| 161 | True hermaphroditism (HP:0010459) | 1.70592452 |
| 162 | Truncal obesity (HP:0001956) | 1.70418393 |
| 163 | Molar tooth sign on MRI (HP:0002419) | 1.69790723 |
| 164 | Abnormality of midbrain morphology (HP:0002418) | 1.69790723 |
| 165 | Neck muscle weakness (HP:0000467) | 1.69617550 |
| 166 | Pigmentary retinal degeneration (HP:0001146) | 1.69240802 |
| 167 | Hyperpituitarism (HP:0010514) | 1.67314452 |
| 168 | Tibial bowing (HP:0002982) | 1.67250256 |
| 169 | Inappropriate behavior (HP:0000719) | 1.66923846 |
| 170 | Abnormality of the lumbar spine (HP:0100712) | 1.66163809 |
| 171 | Hemorrhage of the eye (HP:0011885) | 1.65929027 |
| 172 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.64960649 |
| 173 | Laryngomalacia (HP:0001601) | 1.64256272 |
| 174 | Widely spaced teeth (HP:0000687) | 1.64080110 |
| 175 | Ketoacidosis (HP:0001993) | 1.63874546 |
| 176 | Pancreatic fibrosis (HP:0100732) | 1.63858035 |
| 177 | Distal lower limb muscle weakness (HP:0009053) | 1.63788524 |
| 178 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.63004731 |
| 179 | Subcapsular cataract (HP:0000523) | 1.61553028 |
| 180 | Macular degeneration (HP:0000608) | 1.61011691 |
| 181 | Cone-rod dystrophy (HP:0000548) | 1.58782586 |
| 182 | Alacrima (HP:0000522) | 1.57767387 |
| 183 | Abnormality of the 4th metacarpal (HP:0010012) | 1.57135107 |
| 184 | Central scotoma (HP:0000603) | 1.55332056 |
| 185 | Hydroureter (HP:0000072) | 1.54883497 |
| 186 | Aplasia cutis congenita (HP:0001057) | 1.54515443 |
| 187 | Generalized hypopigmentation (HP:0007513) | 1.54021401 |
| 188 | Abnormal ciliary motility (HP:0012262) | 1.53534678 |
| 189 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.53464536 |
| 190 | Growth hormone excess (HP:0000845) | 1.53124969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 7.13566233 |
| 2 | AKT3 | 7.07443297 |
| 3 | FRK | 6.63083469 |
| 4 | MAP3K9 | 4.39743327 |
| 5 | RIPK4 | 3.21603545 |
| 6 | IRAK3 | 3.16506215 |
| 7 | ACVR1B | 2.84064447 |
| 8 | MAP3K13 | 2.82888895 |
| 9 | WNK4 | 2.59008057 |
| 10 | LATS1 | 2.56907153 |
| 11 | TLK1 | 2.44056546 |
| 12 | MAP2K6 | 2.24912620 |
| 13 | ZAK | 2.17862974 |
| 14 | LMTK2 | 2.08762647 |
| 15 | TAOK3 | 1.96842326 |
| 16 | MYLK | 1.93925909 |
| 17 | EPHA3 | 1.85361719 |
| 18 | CASK | 1.81420466 |
| 19 | INSRR | 1.80497881 |
| 20 | EPHB1 | 1.79089232 |
| 21 | FGFR4 | 1.77781256 |
| 22 | IRAK4 | 1.77154290 |
| 23 | CAMK1G | 1.57495407 |
| 24 | BLK | 1.54999035 |
| 25 | SGK2 | 1.44080614 |
| 26 | NTRK1 | 1.40740846 |
| 27 | IRAK2 | 1.39998926 |
| 28 | EPHB2 | 1.38717924 |
| 29 | EPHA4 | 1.38584616 |
| 30 | IRAK1 | 1.37265945 |
| 31 | CAMK1D | 1.31811637 |
| 32 | PNCK | 1.29185936 |
| 33 | PTK2B | 1.27853662 |
| 34 | DMPK | 1.27630868 |
| 35 | NTRK2 | 1.23110606 |
| 36 | MST4 | 1.19021700 |
| 37 | TEC | 1.16586193 |
| 38 | CDK12 | 1.15851596 |
| 39 | SIK1 | 1.15222142 |
| 40 | MARK1 | 1.07058043 |
| 41 | JAK1 | 1.06850816 |
| 42 | STK39 | 1.05524035 |
| 43 | TGFBR1 | 1.04399334 |
| 44 | WNK1 | 0.98861494 |
| 45 | NUAK1 | 0.97318458 |
| 46 | ERN1 | 0.96171945 |
| 47 | PIK3CA | 0.95625436 |
| 48 | NEK2 | 0.93428197 |
| 49 | GRK5 | 0.93208666 |
| 50 | TXK | 0.90786431 |
| 51 | PIK3CG | 0.90381389 |
| 52 | TNK2 | 0.90037727 |
| 53 | SGK223 | 0.89090979 |
| 54 | SGK494 | 0.89090979 |
| 55 | ARAF | 0.89067932 |
| 56 | MAP2K4 | 0.89049033 |
| 57 | PAK3 | 0.88807420 |
| 58 | MATK | 0.85375104 |
| 59 | RIPK1 | 0.84124289 |
| 60 | TNIK | 0.83284480 |
| 61 | SGK3 | 0.82624042 |
| 62 | CDC42BPA | 0.81607120 |
| 63 | NTRK3 | 0.81124977 |
| 64 | MAP3K14 | 0.81090778 |
| 65 | DAPK2 | 0.80118813 |
| 66 | MKNK2 | 0.79715653 |
| 67 | MUSK | 0.79476780 |
| 68 | EIF2AK2 | 0.78439454 |
| 69 | PRKCH | 0.76690701 |
| 70 | BMX | 0.76157080 |
| 71 | TAOK1 | 0.72614152 |
| 72 | SGK1 | 0.71810587 |
| 73 | CHUK | 0.69950009 |
| 74 | JAK2 | 0.69747918 |
| 75 | TRPM7 | 0.69655665 |
| 76 | STK38 | 0.69231673 |
| 77 | MAPK4 | 0.69008255 |
| 78 | SIK2 | 0.68830577 |
| 79 | DAPK3 | 0.68026076 |
| 80 | STK16 | 0.67014323 |
| 81 | ERBB4 | 0.66628445 |
| 82 | MAPK11 | 0.66562722 |
| 83 | ADRBK1 | 0.66430960 |
| 84 | FGR | 0.66241455 |
| 85 | PDK2 | 0.64641925 |
| 86 | DDR2 | 0.63821193 |
| 87 | MAP3K7 | 0.63712077 |
| 88 | BCR | 0.63711046 |
| 89 | PKN1 | 0.63462437 |
| 90 | MAPKAPK3 | 0.63267235 |
| 91 | ADRBK2 | 0.62721415 |
| 92 | MAP2K1 | 0.62318646 |
| 93 | MAP3K12 | 0.60881596 |
| 94 | NEK9 | 0.60323242 |
| 95 | FLT3 | 0.60207666 |
| 96 | EEF2K | 0.58645561 |
| 97 | TTN | 0.58598818 |
| 98 | BMPR1B | 0.56723220 |
| 99 | CSK | 0.56405303 |
| 100 | CDK19 | 0.55357969 |
| 101 | FYN | 0.55295590 |
| 102 | TRIB3 | 0.54441807 |
| 103 | MAP3K4 | 0.54299605 |
| 104 | SYK | 0.51804081 |
| 105 | PRKAA2 | 0.50629543 |
| 106 | PRPF4B | 0.50513855 |
| 107 | MARK3 | 0.48168057 |
| 108 | EGFR | 0.47520640 |
| 109 | FGFR2 | 0.47162338 |
| 110 | TBK1 | 0.47055682 |
| 111 | HIPK2 | 0.45933012 |
| 112 | STK3 | 0.45748941 |
| 113 | MOS | 0.44965975 |
| 114 | MINK1 | 0.43876340 |
| 115 | MARK2 | 0.43837416 |
| 116 | PTK2 | 0.43134832 |
| 117 | PDK1 | 0.42513425 |
| 118 | WNK3 | 0.42151077 |
| 119 | BCKDK | 0.41745079 |
| 120 | LYN | 0.41662466 |
| 121 | CAMK1 | 0.41166002 |
| 122 | MTOR | 0.41082097 |
| 123 | GRK6 | 0.40695336 |
| 124 | CDK5 | 0.40581031 |
| 125 | KIT | 0.39724830 |
| 126 | JAK3 | 0.39723872 |
| 127 | SRC | 0.39424472 |
| 128 | RET | 0.38445612 |
| 129 | GRK7 | 0.38415813 |
| 130 | PRKCZ | 0.37491286 |
| 131 | MST1R | 0.37002482 |
| 132 | MAPK13 | 0.36621979 |
| 133 | BMPR2 | 0.36434806 |
| 134 | PRKACG | 0.35500420 |
| 135 | LRRK2 | 0.35215549 |
| 136 | MAP3K6 | 0.34914699 |
| 137 | PRKCE | 0.34836707 |
| 138 | PRKACA | 0.33986678 |
| 139 | CAMK2A | 0.33912595 |
| 140 | MAPK1 | 0.33137023 |
| 141 | ROCK1 | 0.33039916 |
| 142 | RPS6KA2 | 0.32853578 |
| 143 | PHKG1 | 0.32282114 |
| 144 | PHKG2 | 0.32282114 |
| 145 | MET | 0.32145599 |
| 146 | PRKCD | 0.31905636 |
| 147 | PLK2 | 0.31706242 |
| 148 | PAK2 | 0.31029313 |
| 149 | FER | 0.30546906 |
| 150 | MAP2K7 | 0.30328546 |
| 151 | ALK | 0.30197928 |
| 152 | NLK | 0.30036968 |
| 153 | MAP3K2 | 0.28943133 |
| 154 | PRKACB | 0.27278705 |
| 155 | MAPK8 | 0.26938102 |
| 156 | RPS6KA6 | 0.26840593 |
| 157 | GSK3B | 0.26686142 |
| 158 | WEE1 | 0.26650857 |
| 159 | MKNK1 | 0.23558856 |
| 160 | ERBB3 | 0.21358219 |
| 161 | CAMK4 | 0.21017316 |
| 162 | ICK | 0.20995247 |
| 163 | AKT1 | 0.20983084 |
| 164 | STK11 | 0.19083509 |
| 165 | GRK1 | 0.16550869 |
| 166 | PRKG1 | 0.16383502 |
| 167 | MAPK14 | 0.16280217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.18192852 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.02309766 |
| 3 | ABC transporters_Homo sapiens_hsa02010 | 2.97803631 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.79420077 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.48059569 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.42217490 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.26874236 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.21182150 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.17638983 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.16514930 |
| 11 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.13435252 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07950524 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.05165962 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.98073046 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 1.92312841 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90034198 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.81996910 |
| 18 | Lysine degradation_Homo sapiens_hsa00310 | 1.78475075 |
| 19 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.78201830 |
| 20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.76658278 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.70196310 |
| 22 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.68780788 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68155210 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.67001841 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.65818545 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.63728260 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.60816497 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.60539753 |
| 29 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.57050300 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42174654 |
| 31 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.39962046 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.36161071 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30378311 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29966572 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.29415969 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25959262 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.24230710 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.18667896 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16255878 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14018911 |
| 41 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.12977014 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12871834 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12149142 |
| 44 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.11966237 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11765960 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10787206 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.10210701 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 1.08703158 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08152247 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.08016211 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07524332 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06133297 |
| 53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.04030525 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 1.03142112 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 1.02915631 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02217453 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01426510 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 1.00690766 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96719307 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94332097 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92877866 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92822882 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90972235 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90079768 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89708486 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89648471 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89155044 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88519262 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84313773 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83896077 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83672631 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.83627015 |
| 73 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.83402054 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82785632 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.80347056 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79955923 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.78336392 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77500403 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77128454 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73477694 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71272082 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.67564534 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67136522 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66486193 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65896680 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.64659719 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64603974 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.64257910 |
| 89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63245381 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62908164 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.62805888 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.62642743 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62491676 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61214176 |
| 95 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60788386 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60289194 |
| 97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60027584 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59767754 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58801977 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58608782 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58183551 |
| 102 | Ribosome_Homo sapiens_hsa03010 | 0.57579609 |
| 103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57560539 |
| 104 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57234763 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57146499 |
| 106 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56013186 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54892929 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54558425 |
| 109 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54502338 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54353861 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54202901 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51964328 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50577132 |
| 114 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49946628 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49863702 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49831043 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49442916 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.48177551 |
| 119 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.47906032 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47844074 |
| 121 | Focal adhesion_Homo sapiens_hsa04510 | 0.47559032 |
| 122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47402906 |
| 123 | Influenza A_Homo sapiens_hsa05164 | 0.47059633 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46716534 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46102497 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45689691 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45534886 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44802051 |
| 129 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44384171 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43685581 |
| 131 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43679973 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43548761 |
| 133 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43111499 |
| 134 | Insulin resistance_Homo sapiens_hsa04931 | 0.41792034 |
| 135 | Nicotine addiction_Homo sapiens_hsa05033 | 0.41335600 |
| 136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40996216 |
| 137 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40857385 |
| 138 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40616950 |
| 139 | Homologous recombination_Homo sapiens_hsa03440 | 0.40320698 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40163999 |
| 141 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39900293 |
| 142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39889764 |
| 143 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39715990 |
| 144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38997683 |
| 145 | Hepatitis C_Homo sapiens_hsa05160 | 0.37198937 |
| 146 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36642168 |
| 147 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36203586 |
| 148 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.35898691 |
| 149 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35725858 |
| 150 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.35177819 |
| 151 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32508842 |
| 152 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32300897 |
| 153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31623793 |
| 154 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31185599 |

